Dyrness Albert D. has filed 5 insider transactions across 2 companies since July 2023.
Most recent transaction: a grant/award of 40789 shares of Hyperliquid Strategies Inc ($PURR) on February 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | Hyperliquid Strategies Inc | $PURR | Dyrness Albert D. | Not found | A | Common Stock | 40789 | $0.00 | 41,671.0000 | 124,093,048 | 4624.60% | 0.03% |
| Dec. 2, 2025 | Hyperliquid Strategies Inc | $PURR | Dyrness Albert D. | Not found | J | Common Stock | 882 | $0.00 | 882.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2025 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Dyrness Albert D. | Director | D | Common Stock | 4537 | $0.00 | 0.0000 | 7,077,352 | 100.00% | 0.06% |
| July 11, 2023 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Dyrness Albert D. | Director | A | Common Stock | 4000 | $0.00 | 4,537.0000 | 0 | 744.88% | 0.00% |
| Dec. 11, 2023 | Sonnet BioTherapeutics Holdings, Inc. | $SONN | Dyrness Albert D. | Director | A | Common Stock | 373 | $0.00 | 537.0000 | 0 | 227.44% | 0.00% |